Phase II Study of 21 Day Schedule Oral Etoposide in Children

By the New Agents Group of the United Kingdom Children's Cancer Study Group UKCCSG   Davidson A.   Gowing R.   Lowis S.   Newell D.   Lewis I.   Dicks-Mireaux C.   Pinkerton C.R.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1816-1822

Elsevier

Access to resources Recommend Favorite

Temozolomide: a milestone in the pharmacotherapy of brain tumors

By Weller Michael   Steinbach Joachim P   Wick Wolfgang  

Future Oncology, Vol. 1, Iss. 6, 2005-12 ,pp. : 747-754

Future Medicine

Access to resources Recommend Favorite

Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors

By Ruggiero Antonio  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 513-518

Springer Publishing Company

Access to resources Recommend Favorite

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

By Christodoulou Christos   Bafaloukos Dimitrios   Linardou Helen   Aravantinos Gerassimos   Bamias Aristotelis   Carina Maria   Klouvas George   Skarlos Dimosthenis  

Journal of Neuro-Oncology, Vol. 71, Iss. 1, 2005-01 ,pp. : 61-65

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Clinical Study of Three Times a Day Oral Administration of TAS-102 in Patients with Solid Tumors

By Overman Michael   Kopetz Scott   Varadhachary Gauri   Fukushima Masakazu   Kuwata Keizo   Mita Akira   Wolff Robert   Hoff Paulo   Xiong Henry   Abbruzzese James  

Cancer Investigation, Vol. 26, Iss. 8, 2008-10 ,pp. : 794-799

Informa Healthcare

Access to resources Recommend Favorite